Natco Pharma Overview
- Year Founded
-
1981
- Status
-
Public
- Employees
-
4,762
- Stock Symbol
-
524816
- Investments
-
12
- Share Price
-
$9.86
- (As of Tuesday Closing)
Natco Pharma General Information
Description
Natco Pharma Ltd is a drug manufacturing company. Natco aims to make specialty medicines accessible to all by manufacturing niche pharmaceutical products backed by its research and development capabilities. While the vast majority of the company's revenue is generated in India, the company looks internationally for growth opportunities. The company maintains a presence in Oncology and Hepatology treatment areas. Natco's active pharmaceutical ingredient segment APIs forms a core part of the company's business. The company operates in two different business segments: pharmaceuticals and agrochemicals. It derives maximum revenue from Pharmaceuticals Segment.
Contact Information
Website
www.natcopharma.co.inCorporate Office
- Natco House
- Road No.2, Banjara Hills
- Hyderabad, Andhra Pradesh 500034
- India
Corporate Office
- Natco House
- Road No.2, Banjara Hills
- Hyderabad, Andhra Pradesh 500034
- India
Natco Pharma Stock Performance
As of 22-Apr-2025, Natco Pharma’s stock price is $9.86. Its current market cap is $1.77B with 179M shares.
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $9.86 | $9.73 | $7.72 - $19.51 | $1.77B | 179M | 69.1K | $1.24 |
Natco Pharma Financials Summary
As of 31-Dec-2024, Natco Pharma has a trailing 12-month revenue of $509M.
|
In Thousands, USD |
TTM 31-Dec-2024 | FY 2024 31-Mar-2024 | FY 2023 31-Mar-2023 | FY 2022 31-Mar-2022 |
|---|---|---|---|---|
| EV | 2,627,927 | 1,927,254 | 1,139,930 | 1,768,734 |
| Revenue | 508,721 | 480,614 | 335,862 | 255,665 |
| EBITDA | 282,899 | 213,962 | 122,544 | 42,814 |
| Net Income | 222,894 | 167,698 | 89,081 | 22,816 |
| Total Assets | 828,158 | 689,078 | 673,772 | |
| Total Debt | 0 | 46,299 | 21,449 | 56,971 |
Natco Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Natco Pharma Comparisons
Industry
Financing
Details
Natco Pharma Competitors (9)
One of Natco Pharma’s 9 competitors is Gland Pharma, a Formerly PE-Backed company based in Hyderabad, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Gland Pharma | Formerly PE-Backed | Hyderabad, India | ||||
| Neuland Laboratories | Corporation | Hyderabad, India | ||||
| Cipla | Corporation | Mumbai, India | ||||
| Granules India | Corporation | Hyderabad, India | ||||
| Emcure Pharmaceuticals | Formerly PE-Backed | Pune, India |
Natco Pharma Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Natco Pharma Patents
Natco Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250026732-A1 | An improved process for the preparation of crystalline form-a of cyantraniliprole | Pending | 24-Nov-2021 | ||
| CA-3231996-A1 | An improved process for the preparation of ruxolitinib phosphate | Pending | 18-Sep-2021 | ||
| US-20240376102-A1 | An improved process for the preparation of ruxolitinib phosphate | Pending | 18-Sep-2021 | ||
| CA-3229559-A1 | Novel crystalline polymorph of lurbinectedin and improved process for the preparation of lurbinectedin | Pending | 31-Aug-2021 | ||
| US-20240294549-A1 | An improved process for the preparation of trabectedin | Pending | 31-Aug-2021 | C07D515/22 |
Natco Pharma Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Natco Pharma Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Natco Pharma Investments & Acquisitions (12)
Natco Pharma’s most recent deal was a Later Stage VC with Egenesis for . The deal was made on 04-Sep-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Egenesis | 04-Sep-2024 | Later Stage VC | Biotechnology | ||
| Cellogen Therapeutics | 17-Jan-2024 | Corporate | Biotechnology | ||
| Pee Safe | 12-Sep-2023 | Later Stage VC | Personal Products | ||
| ISCA | 31-Aug-2023 | Corporate | Other Consumer Durables | ||
| NATCO Lotus Farma | 20-Apr-2023 | Joint Venture | Pharmaceuticals |
Natco Pharma ESG
Risk Overview
Risk Rating
Updated November, 22, 2024
30.96 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 15,109
Rank
Percentile
Pharmaceuticals
Industry
of 861
Rank
Percentile
Pharmaceuticals
Subindustry
of 430
Rank
Percentile
Natco Pharma Exits (1)
Natco Pharma’s most recent exit was on 12-Jul-2007 from SaveMart Pharmacy. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| SaveMart Pharmacy | 12-Jul-2007 | Completed |
|
Natco Pharma Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| K & C Pharmacy |
Natco Pharma FAQs
-
When was Natco Pharma founded?
Natco Pharma was founded in 1981.
-
Where is Natco Pharma headquartered?
Natco Pharma is headquartered in Hyderabad, India.
-
What is the size of Natco Pharma?
Natco Pharma has 4,762 total employees.
-
What industry is Natco Pharma in?
Natco Pharma’s primary industry is Pharmaceuticals.
-
Is Natco Pharma a private or public company?
Natco Pharma is a Public company.
-
What is Natco Pharma’s stock symbol?
The ticker symbol for Natco Pharma is 524816.
-
What is the current stock price of Natco Pharma?
As of 22-Apr-2025 the stock price of Natco Pharma is $9.86.
-
What is the current market cap of Natco Pharma?
The current market capitalization of Natco Pharma is $1.77B.
-
What is Natco Pharma’s current revenue?
The trailing twelve month revenue for Natco Pharma is $509M.
-
Who are Natco Pharma’s competitors?
Gland Pharma, Neuland Laboratories, Cipla, Granules India, and Emcure Pharmaceuticals are some of the 9 competitors of Natco Pharma.
-
What is Natco Pharma’s annual earnings per share (EPS)?
Natco Pharma’s EPS for 12 months was $1.24.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
